fda glp-1 compounding crackdown september 2025 Compounded GLP-1s Become Illegal, Price Cuts Roll Out FDA Warns Telehealth Firms Over

Uusi-Rasi K et al (2010) Three-month weight reduction does not compromise bone strength in obese premenopausal women

Indian J Endocrinol Metab (2015) 19(1):308

Joint replacement surgeries cost $30,000 to $50,000 each

Eli Lilly's core tirzepatide patents don't expire until 2036-2037, and formulation patents extend through 2040

GLP-1 Users Want Products to Meet Their Needs About one in three current users say they have come across products marketed specifically for GLP-1 users, and more than half of current users would be more likely to purchase some products if they catered specifically to those on GLP-1 medications

An online pharmacy representative described it: There is no standardized way to compare self-reported weight with submitted photos, leading to potential errors. This gap increases variability within verification and puts the safety of patients and regulations aligned with the healthcare system at risk